ACN Newswire

TOKYO, May 18, 2017 - (JCN Newswire) - NEC Corporation (TSE:6701) today announced that it will conduct a trial of remote construction technologies with KDDI Corporation and Obayashi Corporation, with the aim of achieving smart civil engineering utilizing 5G, the next-generation wireless communication standard.

The trial aims to verify the improved workability and quality of remote construction by applying the large-capacity, low-latency communication featured in 5G to construction machinery, thereby enabling the transmission of high-definition video that is difficult to achieve with existing mobile communications.

The companies will undertake verification by combining 5G wireless infrastructure with an existing remote control system for construction machinery. In the experiment, video taken by multiple units of high-definition 4K cameras mounted in construction machinery will be transmitted to the remote controller via 5G wireless infrastructure utilizing beamforming through a multi-element antenna supporting the 28GHz band.

Unlike existing LTE and Wi-Fi networks, 5G wireless infrastructure is capable of high-speed transmission of large-capacity, high-definition video with low-latency. This allows workers to conveniently gain an accurate impression of a situation using high-definition video sent from remotely located construction machinery. Moreover, the three companies will also verify advances in construction quality and efficiency through improved remote control workability, such as real-time changes in the position and direction of construction machinery.

"We expect that 5G will play an essential role in developing a better society through collaboration with a variety of industries and that 5G will contribute to improvement of the quality of construction and civil engineering," said Akira Matsunaga, Senior Director, Mobile Network Technical Development, KDDI Corporation. "We sincerely wish that the trial this time will verify the advantages of 5G in the application of construction engineering and that we can move forward towards the realization of a better society."

"The introduction of robotics to the construction field, including remote-control capabilities, is making substantial progress," said Hideo Katsumata, Executive Officer / General Manager, Technical Research Institute, Obayashi Corporation. "We believe that the 5G communication technology opens the possibility of greatly advancing the operation of construction robots. Going forward, we will continue to promote research and development in 5G-enabled, remotely controlled robots that can be utilized for a wide range of construction purposes."

"NEC is very pleased to participate in this trial with KDDI and Obayashi in order to achieve smart civil engineering utilizing 5G," said Tomonori Kumagai, General Manager, Business Development Division, NEC Corporation. "The multi-element antenna system and its control technology, which are currently undergoing research and development at NEC, are essential for implementing large-capacity, low-latency 5G. Going forward, we will continue to promote research and development in support of future commercial services."

About NEC Corporation

NEC Corporation is a leader in the integration of IT and network technologies that benefit businesses and people around the world. By providing a combination of products and solutions that cross utilize the company's experience and global resources, NEC's advanced technologies meet the complex and ever-changing needs of its customers. NEC brings more than 100 years of expertise in technological innovation to empower people, businesses and society. For more information, visit NEC at http://www.nec.com.

Based on its Mid-term Management Plan 2015, the NEC Group globally provides "Solutions for Society" that promote the safety, security, efficiency and equality of society. Under the company's corporate message of "Orchestrating a brighter world," NEC aims to help solve a wide range of challenging issues and to create new social value for the changing world of tomorrow. For more information, please visit http://www.nec.com/en/global/about/solutionsforsociety/message.html.

Contact:
NEC 
Seiichiro Toda         
s-toda@cj.jp.nec.com 
+81-3-3798-6511

Speech by Mr. Ando, MHPS President & CEO

Opening Ceremony

Yokohama, Japan, May 18, 2017 - (JCN Newswire) - Mitsubishi Hitachi Power Systems (MHPS) is delighted to announce the opening of a new office in Warsaw, Poland, to strengthen its relationships with local customers and bolster orders for advanced coal-fired power generation systems and Air Quality Control Systems (AQCS).

The new branch office brings MHPS's corporate functions in Poland together in one location and will serve as MHPS's business development function for the country, with the goal of improving customer support and satisfaction.

The opening ceremony was attended by delegates from the Polish Ministry of Energy and Ambassador Shigeo Matsutomi of the Embassy of Japan in Poland, as well as guests from the energy sector. Also in attendance were MHPS President and CEO, Kenji Ando, MHPS Vice-President, Yasuo Fujitani, and CEO of MHPS Europe GmbH, Rainer Kiechl.

"Poland is one of the most dynamic markets for energy plant construction. With our know-how and technological market leadership, we hope to participate in this growth as a partner to our Polish customers and stakeholders," said Rainer Kiechl, CEO of MHPS Europe GmbH. "I am convinced that the Mitsubishi Hitachi Power Systems group has the best skills and the right expertise for this task."

Poland is a world leader in terms of coal resources, with approximately 90% of the country's electricity generated by coal-fired power stations. The Polish Government aims to revitalize the country's coal industry and strengthen its energy security. Efforts are underway to rationalize coal mines and introduce facilities that utilize sub-bituminous and brown coal (major elements of Poland's coal reserves) while promoting air quality control systems (AQCS) technology.

MHPS offers high-efficiency proprietary power generation technologies which utilize a variety of coals, and has an excellent track record delivering such facilities in Poland. It received orders to supply bituminous coal-fired power generation equipment (with a capacity of 1,075 MW) for Unit 11 of the Kozienice thermal power plant, operated by Polish power company ENEA Wytwarzanie SA. The new unit is due to begin operations in December 2017. MHPS completed the delivery of an advanced flue gas denitration facility for Units 1 and 2 of the plant in 2016.

MHPS also received orders to supply lignite-fired power generation equipment for Unit 11 of the Turow thermal power station, operated by state power company PGK (Polska Grupa Energetyczna SA). Construction of the new unit is underway and operations are due to commence in 2020.

About Mitsubishi Hitachi Power Systems, Ltd.

Mitsubishi Hitachi Power Systems, Ltd. (MHPS) was formed on February 1 2014, integrating the thermal power generation systems businesses of Mitsubishi Heavy Industries, Ltd. (MHI) and Hitachi, Ltd. in a quest to further enhance their social response capabilities in all respects. These include the technological strength to create new products of outstanding quality and reliability, the comprehensive strength in engineering to oversee projects in regions across the globe, and finely honed sales and after-sale servicing capabilities. MHPS aims to come out a winner in global competition and achieve a solid position as a world leader in thermal power generation systems and environmental technologies. For more information, please visit www.mhps.com.

Contact:
Mitsubishi Heavy Industries
Joseph Hood, PR Manager
Email: mhi-pr@mhi.co.jp
Tel: +81-(0)3-6716-2168
Fax: +81-(0)3-6716-5860

- Biomarker two-arm study in 26 Soft Tissue Sarcoma patients
- Data shows a specific, adaptive immune pattern triggered by NBTXR3 treatment
- Potential synergies with Immuno-oncology drugs including checkpoint inhibitors

Paris, France and Cambridge, Massachusetts, USA, May 18, 2017 - (ACN Newswire) - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced its first set of clinical data from its immuno-oncology (IO) program, showing the potential ability of NBTXR3 to transform "cold" tumors into "hot" tumors.

Laurent Levy, CEO of Nanobiotix said, "Being able to transform cold tumors into hot tumors is one of the most challenging and promising topics in oncology. This preliminary clinical data indicates that NBTXR3 could play a key role in unlocking this potential. Given NBTXR3's universal type mode of action and good safety profile, NBTXR3 could change the treatment landscape in numerous solid tumor cancers."

Many tumors exhibit little or no response to therapies targeting the immune system and are considered "cold". The explanation for the lack of response in its simplest form is a lack of immunogenicity. The ability of NBTXR3 to generate intratumoral immunogenic cell death (ICD) could be a key to significantly increase the number of patients who can engage their immune system to fight their cancer.

To undertake this research, Nanobiotix used the available patient samples from its more advanced indication of soft tissue sarcoma -- a typical "cold" tumor. These findings demontrated that NBTXR3 plus radiotherapy induces a specific adaptive immune pattern, which could potentially contribute to converting a "cold" tumor into a "hot" tumor. In this study, radiotherapy alone did not show any impact on triggering adaptive immune response.

Key Results

- Specific adaptive immune pattern induced by NBTXR3 when exposed to radiation therapy in Soft Tissue Sarcoma (STS) patients (#e14615)
Jerome Galon, Marick Lae, Zsuzsanna Papai, Philippe Rochaix, Laszlo Csaba Mangel, Bernhard Mlecnik, Fabienne Hermitte, Zoltan Sapi, Martine Delannes, Tamas Tornoczky, Anne Vincent-Salomon, Sylvie Bonvalot; INSERM, Paris, France; Institut Curie, Paris, France; Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, Hungary; Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France; Pecs University, Pecs, Hungary; HalioDX, Marseille, France; Semmelweis University, Budapest, Hungary.

In this study, tumors from the ongoing two-arm Phase II/III clinical trial were examined both pre- and post-treatment in patients with locally advanced soft tissue sarcoma who had received either NBTXR3 with radiotherapy (14 patients) or radiotherapy alone (12 patients).

The results observed in the post-treatment examination of patients who received both NBTXR3 and radiotherapy, showed a significant increase of immune cell infiltration (CD3+, CD8+). In contrast, there were no differences observed between pre- and post-treatment examination where patients received radiotherapy alone. Similarly, patients who received NBTXR3 plus radiotherapy were found to have an increased immunoscore post-treatment, compared to those who received radiotherapy alone.

The upregulation of pan-immune gene expression and specifically, the expression of adaptive immunity genes between pre- and post-treatment, was pronounced in the post-treatment results of patients who received NBTXR3 plus radiotherapy compared to those who received radiotherapy alone.

Furthermore, a functional analysis of upregulated genes in NBTXR3 plus radiotherapy showed a specific enrichment of cytokine activity (IL7, IFNA, IL16, IL11, IFNG), adaptive immunity (RAG1, GZMA, TAP1, TAP2, TBX21, STAT4, IFNG, LCK, LTK, CD37, CD22) and T-cell receptor signaling pathway (CD28, CTLA4, CD274, BTLA, TIGIT, CD40LG, CD5, CD3E, ZAP70).

The initial data suggests NBTXR3's potential as an IO agent that could, on its own, trigger a specific immune response against the tumor. A number of upregulated genes correspond to existing or promising IO targets, enabling potential combination of NBTXR3 with therapeutic approaches, like products targeting PD1, PDL1, CTLA4, etc. This data requires confirmation in additional studies.

- NBTXR3 competitive positioning in IO

Many IO combination strategies focus on 'priming' the tumor, which is now becoming a prerequisite of turning a "cold" tumor into a "hot" tumor.

Compared to other modalities that could be used for priming the tumor, NBTXR3 could have a number of advantages: the physical and universal mode of action that could be used widely across oncology, the one-time local injection and good fit within existing medical practice already used as a basis for cancer treatment, as well as a very good chronic safety profile and well-established manufacturing process.

The new clinical data and previous pre-clinical data indicate that NBTXR3 could play a key role in oncology and could become a backbone in immuno-oncology.

About NBTXR3

Nanobiotix's lead product, NBTXR3, is a first-in-class radio-enhancer nanoparticle designed for direct injection into cancerous tumors. It has been engineered to increase the dose and efficacy of radiotherapy without increasing toxicity or causing damage to surrounding healthy tissues. NBTXR3 is currently in late-stage clinical development as a single agent.

Worldwide clinical development of NBTXR3 now includes trials across 7 patient populations:

- Soft Tissue Sarcoma (STS)
Phase I/II trial completed
Phase II/III "Act.in.Sarc." global trial (including EU, South Africa and Asia-Pacific region)

- Head and Neck Cancer
Phase I/II trial in France and Spain; NBTXR3 + Radiotherapy alone
Phase I/II trial by PharmaEngine in Asia-Pacific; NBTXR3 + Radiotherapy & Chemotherapy

- Prostate Cancer
Phase I/II trial in the U.S

- Liver Cancers
Phase I/II Hepatocellular Cancer trial in France
Phase I/II Liver Metastases trial in France

- Rectal Cancer
Phase I/II trial by PharmaEngine in Asia-Pacific
First market approval has been filed in the EU.

About NANOBIOTIX www.nanobiotix.com

Nanobiotix (Euronext: NANO / ISIN: FR0011341205) is a late clinical-stage nanomedicine company pioneering novel approaches for the treatment of cancer. The Company's first-in-class, proprietary technology, NanoXray, enhances radiotherapy energy with a view to provide a new, more efficient treatment for cancer patients.

NanoXray products are compatible with current radiotherapy treatments and are meant to treat potentially a wide variety of solid tumors including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, glioblastoma, etc., via multiple routes of administration.

NBTXR3 is being evaluated in: soft tissue sarcoma (STS), head and neck cancers, prostate cancer, and liver cancers (primary and metastases). Additionally, head and neck cancer and rectal cancer trials led by Nanobiotix's Taiwanese partner, PharmaEngine, are underway in the Asia Pacific region. The Company has filed in August 2016 for market approval (CE Marking) in Europe for its lead product NBTXR3.

The Company started in 2016 a new preclinical research program in Immuno-oncology with its lead product NBTXR3, which could have the potential to bring a new dimension to cancer immunotherapies.

Nanobiotix is listed on the regulated market of Euronext in Paris (ISIN: FR0011341205, Euronext ticker: NANO, Bloomberg: NANO: FP). The Company Headquarter is based in Paris, France. Affiliate in Cambridge, United States.

Contact

Nanobiotix
Sarah Gaubert
Director, Communications & Public Affairs
+33 (0)1 40 26 07 55
sarah.gaubert@nanobiotix.com / contact@nanobiotix.com

Noel Kurdi
Director, Investor Relations
+1 (646) 241-4400
noel.kurdi@nanobiotix.com / investors@nanobiotix.com

Media relations
France - Springbok Consultants
Marina Rosoff
+33 (0)6 71 58 00 34
marina@springbok.fr

United States - RooneyPartners
Marion Janic
+1 (212) 223-4017
mjanic@rooneyco.com

Disclaimer

This press release contains certain forward-looking statements concerning Nanobiotix and its business. Such forward-looking statements are based on assumptions that Nanobiotix considers to be reasonable. However, there can be no assurance that the estimates contained in such forward-looking statements will be verified, which estimates are subject to numerous risks including the risks set forth in the reference document of Nanobiotix filed with the French Financial Markets Authority (Autorite des Marches Financiers) under number D.17-0470 on April 28, 2017 (a copy of which is available on www.nanobiotix.com) and to the development of economic conditions, financial markets and the markets in which Nanobiotix operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Nanobiotix or not currently considered material by Nanobiotix. The occurrence of all or part of such risks could cause actual results, financial conditions, performance or achievements of Nanobiotix to be materially different from such forward-looking statements.

This press release and the information that it contains do not constitute an offer to sell or subscribe for, or a solicitation of an offer to purchase or subscribe for, Nanobiotix shares in any country. At the moment NBTXR3 does not bear a CE mark and is not permitted to be placed on the market or put into service until NBTXR3 has obtained a CE mark.

JAKARTA, INDONESIA, May 18, 2017 - (ACN Newswire) - Wintermar Offshore Marine (WINS) Shareholders have approved the proposal to issue 400 million new shares without pre-emptive rights. In compliance with OJK regulations, the minimum price for the placement will be IDR258.48 and the approval is valid for a period of two years from 18 May 2017 to 18 May 2019.

The placement of shares will provide the WINS Group with access to funding during the next two years. Cash raised from the fund raising will be used to reduce debt, provide working capital and funding for business development. With the increase in equity, the capital structure of the company will also be strengthened.

The shares will be placed to affiliated parties who have committed to a twelve month 'lock up' period, as prescribed by OJK Regulations, within which time the shares cannot be sold.

The Shareholders also approved the appointment of the following new Directors to the Board:

1) Mr Adhi Pradnyana Gaduh -
Mr Gaduh has a wealth of experience in Strategy with the Gajah Tunggal Group and previously from Boston Consulting Group. He holds a Bachelors degree in Electrical engineering from University of California, Berkeley and a Masters of Business Administration from Stanford University.

2) Mr Donny Indrasworo -
Mr Indrasworo has been with the Group as the Head of Commercial and Business Development for the Wintermar Group. He holds a Bachelors degree with double majors in Economics and Business Administration from Hogeschool Inholland, University of Applied Sciences in Amsterdam.

3) Mr Darmawan Layanto -
Mr Layanto has been instrumental in the growth of Wintermar?s fleet for the past 17 years in the Shipbuilding and Technical Division. He will relinquish his role as Commissioner and become a Director where he will have a more active day to day role. He holds a Bachelors degree in Management from Golden Gate University.

The Shareholders have also accepted the retirement and resignation of the below Directors:

1) Mr Endo Rasdja who has served as Independent Director since 2010 has retired, and
2) Mr Marc Thomson resigned from the Company in March 2017 to pursue his personal business interests.

Mr John Stuart Anderson Slack, who has served as Director since 2013, will step down from the Board of Directors and be appointed as a Commissioner of the Company with immediate effect. He will continue to be actively involved with the Company in his new role. Mr Slack is a Chartered Accountant with many years of experience in various listed companies in Indonesia and graduated from the University of Manchester, Institute of Science and Technology.

About Wintermar Offshore Marine Group

Wintermar Offshore Marine Group (WINS.ID), developed over 40 years and whose track record of quality is both a source of pride and a responsibility that we are dedicated to upholding, sails a fleet of more than 70 Offshore Support Vessels ready for long term as well as spot charters, all operated by experienced Indonesian crew and tracked by satellite systems and monitored in real time by shore based Vessel Teams.

In 2011, Wintermar became the first shipping company in Indonesia to be certified with an Integrated Management System by Lloyd's Register Quality Assurance, comprising ISO 9001:2008 (Quality), ISO14001:2004 (Environment) and OHSAS 18001:2007 (Occupational Health and Safety). For more information, please visit www.wintermar.com.

Contact:
Ms. Pek Swan Layanto
Investor Relations
PT Wintermar Offshore Marine Tbk
Tel  +62 21 530 5201 Ext 401
Email: investor_relations@wintermar.com

The HKBU research team: (From left) Professor Zhang Ge, Dr Liang Chao, Miss Wang Luyao and Professor Lyu Aiping (Copyright: Hong Kong Baptist University)

(From left) Miss Wang Luyao, Professor Zhang Ge and Dr Liang Chao witness the launch of Tianzhou-1 at the Wenchang Space Launch Centre in Hainan. (Copyright: Hong Kong Baptist University)

In vivo osteoblast-specific delivery of CKIP-1 siRNA could improve bone formation and increase bone mass of aged rats dramatically. (Copyright: Hong Kong Baptist University)

HONG KONG, May 18, 2017 - (ACN Newswire) - The School of Chinese Medicine (SCM) of Hong Kong Baptist University (HKBU) is conducting a space life science study aboard China's first cargo spacecraft, Tianzhou-1, which was launched last month. HKBU is the only institution of higher education outside the Mainland to conduct scientific research aboard the Tianzhou 1.

The HKBU team is studying effects of the CKIP-1 gene on bone formation in the microgravity condition on board the Tianzhou 1 in space. In microgravity, bone loss occurs several times faster than on Earth, posing a serious health threat to astronauts, who therefore cannot stay in space for long periods of time. The HKBU team hopes that the study will lead to the formulation of a set of protective measures and treatments as well as the discovery of new drugs to prevent or treat bone loss resulting from space travel. It could also serve as reference for the development of a health care and therapeutics for an ageing population.

The HKBU team is led by Professor Lyu Aiping, HKBU Dean of Chinese Medicine, and Director of the Law Sau Fai Institute for Advancing Translational Medicine in Bone & Joint Diseases (TMBJ), and Professor Zhang Ge, Associate Director of TMBJ, Associate Director of SCM's Teaching and Research Division, and Director of the Technology Development Division, with Post-doctoral Research Fellow Dr Liang Chao and Senior Research Assistant Miss Wang Luyao as team members.

Professor Lyu Aiping said this is another important contribution made by HKBU to the Mainland's major scientific research initiatives after its participation in the first deep-sea expedition aboard the manned submersible Jiaolong in 2013. This new contribution not only recognises HKBU's and Hong Kong's research strength in related areas, but is also a great source of encouragement to members of the Chinese medicine and higher education sectors.

Professor Zhang Ge says the quality of Bone & Joint Research at TMBJ has reached the top international level. TMBJ members have in recent years published a number of research papers in prestigious academic journals such as Nature Communications and Nature Medicine. He hopes their project will bring a breakthrough in this related area of research.

The CKIP-1 gene in osteoblasts (bone-forming cells) could specifically interact with SMURF1 genes in the cells to inhibit cell activity, thereby slowing down or hindering bone formation. The research team led by Professor Lyu and Professor Zhang further found that the aberrant elevated CKIP-1 expression in osteoblast could inhibit bone formation and contribute to the reduction in bone formation during ageing as well as in the development of glucocorticoid-induced osteoporosis.

Nevertheless, the function of CKIP-1 in the process of bone formation reduction caused by microgravity in space is still not yet known. The team has placed osteoblast in which CKIP-1 genes were silenced on board the Tianzhou 1 for further research, and is monitoring the effects of CKIP-1 on osteoblast.

To prepare for the launch of Tianzhou 1, Dr Liang Chao and Miss Wang Luyao of the HKBU team participated in a number of life science experiments at ground level, organised by the National Space Science and Application Centre of the Chinese Academy of Sciences. These experiments included simulated vibration tests, bio-compatibility tests and simulated microgravity experiments as well as systematic matching experiments and rehearsals. Tianzhou 1 was launched at the Wenchang Space Launch Centre in Hainan.

Entitled "Research on the impact of microgravity on the proliferation and differentiation of cells", the space life science study on Tianzhou 1 is led by Northwestern Polytechnical University in collaboration with HKBU, Tsinghua University, Zhejiang University, the Academy of Military Medical Sciences, and the Institute of Zoology of the Chinese Academy of Sciences. The project consists of eight sub-projects of which HKBU is responsible for sub-project CKIP 1.

Media enquiries:
Connie Ko of the School of Chinese Medicine (+852 3411 2132) or
M S Fung of the Communication and Public Relations Office (+852 3411 5261 or +852 7472 2122).

Hong Kong International Medical Devices and Supplies Fair Draws 10,700 Buyers

More than 10,700 Buyers Visited the Fair, Up 7% over Last Year

HONG KONG, May 18, 2017 - (ACN Newswire) - The eighth HKTDC Hong Kong International Medical Devices and Supplies Fair concluded its three-day run today. Organised by the Hong Kong Trade Development Council (HKTDC) and co-organised by the Hong Kong Medical and Healthcare Device Industries Association (HKMHDIA), the fair welcomed more than 10,700 buyers from 62 countries and regions, up 7 per cent over the previous year.

Fair Video: https://youtu.be/vXsBp23PASw

"With the ageing population and advancement in medical technologies, there is immense growth potential in the medical supplies and products market," said HKTDC Deputy Executive Director Benjamin Chau. "The Medical Fair showcased a wide selection of medical devices and supplies, attracting industry players from around the world. This year, buyer attendance from mature markets such as Japan, Korea, Switzerland and the UK, together with emerging markets, including the Chinese mainland, India, the Philippines, Thailand and Russia, recorded satisfactory growth, indicating there is flourishing demand for medical products and services across many markets."

- Buyers interested in the latest medical equipment

With the rapid development of the Asian medical market, the Medical Fair attracted many Asian buyers, energising the sourcing atmosphere. OliveNetworks is among the largest health and lifestyle store chains in Korea with over 900 stores. Kim Min Chae, the company's Manager, visited the Medical Fair for the first time to enhance the company's product categories, and established initial contact with five to six potential suppliers from Hong Kong, the mainland and Malaysia. "The fair has a good mix of medical products on offer," said Mr Kim. "Our initial order for back braces is estimated at US$35,000. We are also negotiating with new suppliers for products such as kinesiology tapes."

Max Healthcare is one of the largest hospital groups in northern India, currently operating 14 hospitals with about 2,500 beds. Amid the hospital group's expansion plans, Manoj Ahlawat, General Manager, Supply Chain Management visited the Medical Fair for the first time to source new quality products and technology from Asia. "So far, I have found two potential suppliers for hospital beds that suit our needs. If negotiations work out successfully, the amount of orders will be around US$50,000 each with them."

Singaporean buyer Ziwell Medical(S) Pte Ltd distributes medical devices and health products in Singapore and Malaysia with hospitals, clinics and pharmacies as major customers. Yeo Siew Meng, the company's Director, returned to Hong Kong to find new products and suppliers. So far, he found three potential suppliers from Hong Kong and the mainland for different items such as a smart cart designed to aid patients' mobility, an AED device and an AED training set. "The amount of business for the smart carts is anticipated to be around US$200,000 while that for the AED devices and training sets can be up to US$600,000. The fair provided an ideal platform for us to look for quality business partners."

- New "World of Healthcare" helps explore new markets

This year, the Medical Fair attracted a total of 270 exhibitors from 14 countries and regions. Featuring more than 15 thematic zones, the fair presented a wide spectrum of medical and healthcare devices and services, providing an important business platform for the healthcare industry. Responding to growing awareness of the importance of personal health, the fair introduced the "World of Healthcare" to present healthcare products and services, including fitness products, health food and beverages, and nutritional supplements. The Australian exhibitor Benson Medical Services Pty Ltd, which sells products worldwide, promoted a product that helps relieve snoring and enables people to sleep better. Richard Benson, the company's Director, said that the fair helped the company explore new markets. "We have already received serious interest from potential buyers from the Chinese mainland, India and the Philippines. The feedback is absolutely fantastic."

The US exhibitor MivaTek is an IoT service provider, offering smart home-care solutions to enable independent living for the elderly, such as various sensors for multiple functions like activity tracking. Roger Huang, Senior Sales Director, said he was pleased with the results by showcasing their services in the new zone. "It creates a critical mass to draw buyers looking for healthcare items. We met a number of buyers from different markets, including Hong Kong, India, Singapore, Malaysia, Italy and Germany. Some of them requested samples. We expect to take about three months to negotiate and conclude business cooperation. The responses have met our expectations."

- Start-ups expand their business networks

The medical industry is becoming a popular sector for entrepreneurs, with many start-ups developing new medical products and technologies in recent years. The "Startup" zone, introduced at the Medical Fair this year, allowed start-ups to exhibit at lower cost and meet buyers and potential business partners from around the world. The Hong Kong start-up Human Washer Ltd presented for the first time its automated full bathing system with temperature control, surrounding water jets and warm-air drying. Its Director Samuel Hui said that the Startup zone is an effective platform to present creative ideas to potential buyers from around the world. "The feedback has been terrific. We have got in touch with serious buyers from Singapore and Malaysia, who expressed interest in distributing our device." He added that they were in talks with many Hong Kong contacts including hospitals and elderly care centres that want to order their product.

- New group pavilions explore the Chinese mainland and Asian markets

This year, the Medical Fair welcomed new group pavilions from the US State of Illinois, the Czech Republic, India and Poland's Wielkopolska region to present the latest medical technology products. Milan Vagner, Consul (Trade & Economy), Consulate General of the Czech Republic in Hong Kong, said that they were pleased to have organised a pavilion with four Czech companies to promote nursing beds and orthopaedic shoes, in order to explore the Asian business network. "The ageing population presents a lot of opportunities for our medical businesses. Hong Kong is the hub for doing business in Asia and serves as a gateway to penetrate the Chinese mainland. This fair creates an excellent opportunity to grow our presence and keeps us up-to-date of the Asian market."

Kitty CW Leung, Managing Director - Far East Office, State of Illinois, and Terry LaRocca, Senior International Trade Specialist, Illinois Department of Commerce & Economic Opportunity, said the seven companies in the US state's pavilion provided a variety of medical products and services such as obstetrics and gynecology products and esophageal cooling equipment. "The Medical Fair has a special niche to draw industry players and offers us a great chance to gain exposure and find partners. The pre-arranged business-matching service has also facilitated fruitful exchanges. This is a good place to generate interest and explore new business."

To help industry professionals monitor the pulse of the market and expand their business networks, a series of seminars was organised, covering such topics as the latest technology and market information of the medical and healthcare industries and worldwide medical device regulatory updates, as well as forums and workshops. Offering added synergy, the Hospital Authority Convention 2017 (16-17 May) also brought in more than 5,000 delegates, making it one of Asia-Pacific's largest events for medical professionals.

Hong Kong International Medical Devices and Supplies Fair: www.hktdc.com/hkmedicalfair/
Photo Download Link: http://bit.ly/2ru7PA9

To view press releases in Chinese, please visit http://mediaroom.hktdc.com/

About HKTDC

Established in 1966, the Hong Kong Trade Development Council (HKTDC) is a statutory body dedicated to creating opportunities for Hong Kong's businesses. With more than 40 offices globally, including 13 on the Chinese mainland, the HKTDC promotes Hong Kong as a platform for doing business with China, Asia and the world. With 50 years of experience, the HKTDC organises international exhibitions, conferences and business missions to provide companies, particularly SMEs, with business opportunities on the mainland and in international markets, while providing information via trade publications, research reports and digital channels including the media room. For more information, please visit: www.hktdc.com/aboutus. Follow us on Google+, Twitter @hktdc, LinkedIn.

Google+: https://plus.google.com/+hktdc
Twitter: http://www.twitter.com/hktdc
LinkedIn: http://www.linkedin.com/company/hong-kong-trade-development-council

Contact:
HKTDC
Communication and Public Affairs Department
Joe Kainz
Tel: +852 2584 4216
Email: joe.kainz@hktdc.org

HONG KONG, May 18, 2017 - (ACN Newswire) - Chiho-Tiande Group Limited ("Chiho-Tiande" or the "Group") (Stock code: 976), is pleased to provide business development update after its completion of the acquisition of Scholz Holding GmbH (the "Very Substantial Acquisition") in December 2016. Before the Very Substantial Acquisition, Scholz Holding GmbH and its subsidiaries (the "Scholz Group") was significantly over-leveraged and therefore its equity value was negative. Following a series of the restructuring steps with respect to its financial situation and the significant deleveraging measures carried out by the Group, the performance of Scholz Group has improved since January 2017 which has led to an increase in revenue and ultimately improving the profitability of Chiho-Tiande as a whole.

Based on the unaudited consolidated operating results as extracted from the preliminary consolidated management accounts of Chiho-Tiande, the Board wishes to announce that:

1) For the first quarter ended 31 March 2017, the unaudited revenue of the Group was approximately HK$4,381,775,000, increasing approximately 6 times over that of HK$712,310,000 for the same period ended 31 March 2016;

2) For the first quarter ended 31 March 2017, the unaudited gross profit of the Group was approximately HK$584,257,000, a turnaround from the gross loss of HK$6,532,000 for the same period ended 31 March 2016, making a substantial profit;

3) For the first quarter ended 31 March 2017, the unaudited profit after tax of the Group was approximately HK$201,612,000, a turnaround from the net loss of HK$68,417,000 for the same period ended 31 March 2016, making a substantial net profit after tax.

The Board believes that this represented an important milestone in the Chiho-Tiande's strategy and would like to keep the shareholders of the Group and potential investors informed. The Board does not however intend to release quarterly revenue or profit updates in the future.

The Group was principally engaged in metal recycling, involving the recycling of mixed metal scrap into copper scrap, steel scrap, aluminum scrap, iron scrap and other metal scrap in Asia region during the year 2016. After the completion of the Very Substantial Acquisition, the Group has extended its metal recycling business from Asia region to worldwide (including Europe and North America regions).

The above-mentioned operating results are based on the preliminary consolidated management accounts of the Group, which have not been reviewed or audited by the Company's auditors and may be subject to adjustments. As such, the above information is provided to Shareholders and potential investors for reference only.

About Chiho-Tiande Group Limited (Stock code: 976)
Chiho-Tiande Group Limited completed the acquisition of Scholz Holding GmbH ("Scholz") in December 2016, thus become one of the world's largest mixed metal scrap recyclers, with an international business footprint covering Europe, China and North America. The Group primarily engages in recycling, disassembling and processing of mixed metal scrap and recycle and reuse of resources. It also develops car demolition and e-waste treatment.

For more information, please visit http://www.chiho-tiande.com/

Media enquiries
Strategic Financial Relations Limited
Vicky Lee Tel.: +852 2864 4834 Email : vicky.lee@sprg.com.hk
Hawaii He Tel.: +852 2864 4847 Email : hawaii.he@sprg.com.hk
Fax: +852 2527 1196

Professor Borody, the founder and Medical Director of the Centre for Digestive Diseases (CDD) in Sydney set up the world's first faecal bank in 1988.

Professor Borody, the founder and Medical Director of the Centre for Digestive Diseases (CDD) in Sydney set up the world's first faecal bank in 1988 in surgery at the CDD.

SYDNEY, AU., May 19, 2017 - (ACN Newswire) - Faecal Microbiota Transplantation (FMT) leader Professor Thomas Borody (MD, PhD) has called for a national faecal bank to fight drug resistant and epidemic diseases in hospitals and clinics across the country.

Professor Borody, the Founder and Medical Director of the Centre for Digestive Diseases (CDD) in Sydney was the first in Australia to perform FMT, and he set up the world's first faecal bank in 1988.

Since then CDD has carried out more than 12,000 FMT's and he has trained physicians from around the world in FMT techniques. Now many countries have their own national FMT banks, including several in the US and two in Asia.

"It's time Australia had a national FMT Bank that rapidly provided hospitals and clinics around the country with a high quality, safe, uniform enema product for FMT treatment that will save lives," Prof. Borody said.

Fewer than five hospitals in Australia carry out FMT which means thousands of people are missing out on proven FMT procedures, when at times the only alternative is radical bowel surgery.

"FMT is rapidly becoming the standard practice of care for a range of drug resistant or relapsing diseases including Clostridium difficile infection and Ulcerative Colitis, and research in FMT for Irritable Bowel Syndrome (IBS) is continuing. Some of these conditions can ruin lives and may be fatal."

Prof. Borody initiated a randomized clinical trial in Australia, the results published in the Lancet earlier this year, "The FOCUS study, on effectively treating Ulcerative Colitis using repeated FMT", http://bit.ly/2pY01Gn.

This trial was in part funded by Prof Borody's CDD Research Fund, Broad Medical Research Program, Mount Sinai SUCCESS fund, and the National Health and Medical Research Foundation among others.

Prof. Borody continued, "As more research is done on modern epidemics like Autism, Dementia, obesity, MS and Parkinson's disease, FMT is likely to play a significant role in managing and possibly even curing these conditions."

Most recently Prof. Borody was involved in an Autism study in the US, in which 18 ASD-diagnosed children were treated using FMT. The Trial not only demonstrated progressive improvement in gastrointestinal symptoms commonly present in children with Autism, but also reported significant cognitive improvements beginning in some at five weeks an onwards.

The Autism study was published in January of this year in Microbiome, entitled 'Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study', http://bit.ly/2pY01Gn.

The Australian FMT Bank would require approximately AUD$250K to set up a simple, single unit with an ongoing maintenance fund to run the Bank. Later, a network of centres and donors to supply steady and reliable FMT material for each state would be required.

Ideally it would be federally funded, as it would save the health system millions of dollars per year. However, private support is also an option said Prof. Borody, stating that he would be keen to contribute, given his experience in carrying out 12,000+ FMTs at the state-of-the-art CDD facility in Sydney since 1988.

"At the CDD we already have patients coming in from around the world for FMT treatment. This is a great opportunity for Australian hospitals, with the support of a national FMT Bank, to become world-class FMT providers."

About Faecal Microbiota Transplantation

The human bowel contains a complex population of bacteria known as the gut microbiota. These organisms and the chemicals they produce can affect the bowel and the body as a whole, and these effects can have both positive and negative impacts on a person's health. The human gut microbiota protects us from pathogenic or 'bad' bacteria.

FMT involves the infusion of healthy human donor faecal bacteria via colonoscope or enema into a bowel that contains abnormal bacteria that are making the bowel 'sick'. This infusion process can be a single infusion or it can be repeated over a period of time, depending on the severity of the patient's condition.

The use of healthy human flora appears to be the most complete probiotic treatment available today, capable of eradicating 'bad' bacteria and spores and supplying 'good' bacteria for recolonisation of the gut in certain conditions.

About Prof. Thomas Borody

BSc (MED) (HONS), MBBS (HONS), MD, PhD, DSc, FRACP, FACG, FACP, AGAF
Medical Director, Gastroenterologist, Centre for Digestive Diseases (CDD) -
www.cdd.com.au.

Prof. Thomas Borody is the Founder and Medical Director of CDD. His keen interest in medical research led to the establishment of the Centre to provide both diagnostic procedures and effective treatments.

Prof. Borody has published over 250 articles and abstracts. His knowledge and expertise has been sought after by patients from around the world. He is a reviewer for numerous medical journals and has developed novel therapies in gastrointestinal areas such as Inflammatory Bowel Disease, Irritable Bowel Syndrome, Parasite infestation, ulcer disease and resistant Helicobacter pylori and C. difficile. Prof. Borody continues to conduct research in order to improve current therapies and develop new treatments. To learn more, please see www.cdd.com.au.

Media Contact:
Susan Fitzpatrick-Napier
Digital Mantra Group
Team@dmgpr.com
SG +65 6809 3869
AU +61 2 8218 2144
USA +1 650 798 5238

The celebration event began with welcome speech presented by Mr. Leon Wang, Chief Executive Officer and Executive Director of ASL.

Mr. Wang Weihang, Executive Director of ASL and Chairman and President of Teamsun delivered a video speech at the event.

5 officiating guests including Mr. Leon Wang, Chief Executive Officer and Executive Director of ASL (Right 2), Mr. Li Wei, Chairman and Non-executive Director of ASL (Center), Mr. Pan Xinrong, Independent Non-executive Director of ASL (Left 1), Mr. Leonard Livschitz, Chief Executive Officer of Grid Dynamics (Left 2), and Ms. Victoria Livschitz, Chief Technology Officer of Grid Dynamics (Right 1) hosted the lighting ceremony symbolizing the bright prospects of the Group.

Provides Global Services as a Professional IT Service Partner Firmly Rooted in Hong Kong

HONG KONG, May 19, 2017 - (ACN Newswire) - Automated Systems Holdings Limited ("ASL" or "the Group") (HKG: 771), a trustworthy and professional information technology ("IT") partner in the region, has held "Innovation Journey on Solid Foundation" celebrating ASL's 20th Listing Anniversary cum Joining of Grid Dynamics International, Inc. ("Grid Dynamics") at The Ritz Carlton in Hong Kong today. Guests from different sectors of society attended the event to witness this important historical moment. The Group has also taken this opportunity to express its gratitude to all business partners and different sectors of society for their long-term support while joining the celebration of the Group's outstanding achievements over the past two decades.

The celebration event began with welcome speech presented by Mr. Leon Wang, Chief Executive Officer and Executive Director of ASL and concluded with the executive remarks delivered by Mr. Li Wei, Chairman and Non-executive Director of ASL. Then, the two joined the other officiating guests to host the lighting ceremony symbolizing the bright prospects of the Group. Apart from the event in Hong Kong, ASL's parent company Beijing Teamsun Technology Co., Ltd. has also arranged another celebration event in Beijing on 24 May.

Mr. Leon Wang, Chief Executive Officer and Executive Director of Automated Systems Holdings Limited, said, "2017 is an important year for us to remember and celebrate. It's a milestone that the Group has been founded 44 years and listed on the Main Board of The Stock Exchange of Hong Kong Limited for 20 years. The Group has developed alongside and in close affinity with the IT industry in Hong Kong over the years. Despite many challenges encountered in the past few decades, the Group's core businesses have maintained a healthy development. We have always kept a close watch on changes in the market and actively reviewed and adjusted our development strategy accordingly to build a solid foundation for our business. ASL's success today is owed to the great support from different parties and no words could express the Group's gratitude to them. Taking this opportunity, I would like to thank all our business partners and friends who have worked closely with us all the time."

ASL focuses on and continues to invest in five key solutions areas and services, namely Infrastructure, Security, Data Intelligence, Mobile and Cloud, so as to better grasp the opportunities in the ever-changing market and provide quality and comprehensive IT managed services and solutions to customers. In 2016, the Group expanded "Offshore Delivery Excellence Center" in Guangzhou and opened new "Service Center", further expanding and upgrading the capabilities of the Group. ASL has completed the acquisition of the U.S. cloud services company - Grid Dynamics in April 2017. As such and with firm roots in Hong Kong, the Group has become a global IT service provider with more than 2,000 professionals and an expansion of geographical coverage beyond Asia Pacific.

Mr. Wang continued, "With new generation digital transformation technology emerging and gaining popularity quickly, businesses are having keen interest in pursuing digital transformation. The Group will continue to apply its core edges in seizing the vast opportunities and provide our customers with more comprehensive and highly efficient IT resource management services. The recent acquisition we made have not only expanded our service coverage worldwide, but have also transformed into strong synergies with our existing operations in terms of location, customer base and technology, allowing us to meet the demand of companies around the world. Looking ahead, the Group will continue to capitalize on its strengths and edges to consolidate its standing as an international, reliable and professional IT partner."

About Automated Systems Holdings Limited

Automated Systems (H.K.) Limited was founded in Hong Kong in 1973 and was listed on the Stock Exchange of Hong Kong Limited under the name of Automated Systems Holdings Limited (HKG: 771) in November 1997. ASL Group's ultimate controlling shareholder is Beijing Teamsun Technology Co., Ltd. ("Teamsun") whose shares are listed on the Shanghai Stock Exchange (Stock Code: 600410). The Company is a member of the Teamsun Group which recorded turnover of more than RMB5.0 billion and has more than 5,000 employees.

The ASL Group, consisting of Automated Systems (H.K.) Limited, ELM Computer Technologies Limited, CSA Automated (Macau) Limited, Guangzhou Automated Systems Limited, ASL Automated (Thailand) Limited and the newly acquired company in April 2017 - Grid Dynamics International, Inc.. In addition, i-Sprint Innovations Pte Ltd is our associate company. We offer professional information technology services to corporate clients worldwide, particularly in the Greater China and Asia covering Hong Kong, Mainland China, Taiwan, Macau, Thailand, Singapore, Malaysia as well as North America and Europe, etc. After more than 40 years of success, the ASL Group has established its reputation as a trustworthy and professional global IT partner.

With its strong commitment to quality services, the ASL Group has been winning well-known clients such as government agencies, prestigious universities, telecommunications giants, transportation enterprises, major financial institutions, and leading international corporations. For more information, please visit our web page at http://www.asl.com.hk.

For Press Enquiries:

Strategic Financial Relations Limited
Vicky Lee,
+852 2864 4834, vicky.lee@sprg.com.hk
Janet Fong,
+852 2864 4817, janet.fong @sprg.com.hk
Christina Cheuk,
+852 2114 4979, christina.cheuk@sprg.com.hk
Website: http://www.sprg.com.hk

TOKYO, May 19, 2017 - (JCN Newswire) - Mitsubishi Motors Corporation (MMC) has started a major renovation work of the R&D Center in Okazaki, Aichi Prefecture, which includes the rebuilding of its three main facilities: the main office building, the environment testing facility and the wind tunnel testing facility.

Investment in this project is to be around 33 billion yen. The office building and the environment testing facility are due for completion in fall of 2018, and the wind tunnel testing facility at the beginning of 2020.

Improvements in the work environment and the introduction of the latest equipment will strengthen the company's research and development capabilities, and MMC will move forward to revamp R&D structure for creating next-generation models.

Facility Outline

- Office building

The rebuilt 8-story office building will have a cafeteria and a large conference hall (capacity: 700) available inside. It will have a layout that gives consideration to ease of movement between floors so as to facilitate cross-functional activities. The building is scheduled to provide meeting space for better communication. Some 2,000 employees will be working in design, development, certification and testing.

- Environment testing facility

The environment testing facility will simulate real-life environments and allow the engineers to conduct tests in conditions that include extreme cold temperature (- 40degC) and extreme hot temperature (+50degC) as well as under natural sunlight and in snow.

- Wind tunnel testing facility

The new large-scale wind tunnel will be equipped with a moving belt function that can simulate complex real-life driving situations and will be used to improve aerodynamic characteristics, environmental performance and noise levels.

About Mitsubishi Motors

Mitsubishi Motors Corporation is the fifth largest automaker in Japan and the fifteenth largest in the world by global unit sales. It is part of the Mitsubishi keiretsu, formerly the biggest industrial group in Japan, and was formed in 1970 from the automotive division of Mitsubishi Heavy Industries.

Throughout its history it has courted alliances with foreign partners, a strategy pioneered by their first president Tomio Kubo to encourage expansion, and continued by his successors. A significant stake was sold to Chrysler Corporation in 1971 which it held for 22 years, while DaimlerChrysler was a controlling shareholder between 2000 and 2005. Long term joint manufacturing and technology licencing deals with the Hyundai Motor Company in South Korea and Proton in Malaysia were also forged, while in Europe the company co-owned the largest automobile manufacturing plant in the Netherlands with Volvo for ten years in the 1990s, before taking sole ownership in 2001.

Contact:
Mitsubishi Motors
Public Relations Department
http://www.mitsubishi-motors.com 
+81-3-6852-4275

Acer, ASUS, Advantech, Planet and VIVOTEK to lead the showcase of technologies and innovation around AI, green energy and smart cities, and IoT

SINGAPORE, May 19, 2017 - (ACN Newswire) - This year marks the debut participation of the Taiwan Excellence Pavilion at CommunicAsia 2017. Companies like Acer, Advantech, ASUS, Planet and VIVOTEK, and 14 Taiwan Excellence Award winning brands will be showcasing their latest technologies and innovations in the areas of artificial intelligence, green energy and smart cities, and the Internet of Things (IoT) at the upcoming three-day exhibition slated 23-25 May, at the Marina Bay Sands, BQ2-01, B2.

According to Taiwan External Trade Development Council (TAITRA), the international trade development arm of Taiwan, the event is an avenue to promote Taiwan's leadership in cutting edge technologies and to foster knowledge exchange and deeper partnership with customers, fellow innovators and members of the larger ICT industry.

Taiwan is the 5th largest economy in Asia and currently ranks 10th globally in innovation and 15th in global competitiveness. It has been an indispensable player in the world's high technology sector dominating the global semiconductor market for the past three decades. The country produces three-quarters of the world's integrated circuits and electronic components and accounts for a considerable share of the global computer hardware, and mobile phones. Taiwan is forging its path from being a manufacturing efficiency-focused to an intellectual property- and innovation-driven economy.

"Today's ongoing transformation and changing business models calls for a greater emphasis on innovation. We believe our Taiwanese innovators are well positioned in leveraging Taiwan's technological prowess, strong synergies with the global technology supply chain, and proven strengths in speed, value, flexibility and customization. We are proud of the success stories of companies such as Acer, ASUS, Advantech, Planet and VIVOTEK among others and we proudly present what Taiwan has to offer to the larger ICT industry at CommunicAsia," said Francis Liang Kuo-Hsin, Representative, Taipei Representative Office in Singapore.

One of the key programs under Taiwan's "5+2 Industrial Innovation Plan" is the Asia.Silicon Valley initiative, which aims to establish Taiwan as the hub between the region and Silicon Valley particularly in IoT development, and making the country a global centre for tech entrepreneurship. Taiwan has made inroads with Microsoft and Qualcomm choosing to launch their IoT research centers there.

"We also now have over 140 companies and organizations that have joined the Asia.Silicon Valley IoT alliance including the likes of Acer and Advantech who are showcasing their IoT capabilities at the Taiwan Excellence Pavilion. Through CommunicAsia, we hope to be able to reach not only our trading and technology partners but also to encourage talents from Southeast Asia who are looking into opportunities to join Taiwanese companies at some of today's emerging sectors," said Mr. Liang.

Taiwan Excellence Pavilion will feature products and technologies that have been distinguished with the 'Taiwan Excellence Award', the highest accolade bestowed upon Taiwan-originated products based on their excellence in design, quality, marketing, Taiwanese R&D, and manufacturing. At Asia's premier sourcing and ICT knowledge platform, 19 Taiwan Excellence brands including Acer, Advantech, ASUS, Aver, Beseye, D-link, Edimax, Inwin, Kingmax, LWO, MSI, Planet, Plustek, PX, Sapido, Thermaltake, Transcend, uHandy and VIVOTEK will feature 50 innovative products at the Taiwan Excellence Pavilion over the three-day show.

Taiwan Excellence 2017 Showcase Highlights

- Acer
Acer's abPBX is a revolutionary alternative that takes the approach of a software-defined communication service (SDX). It also offers a major advancement in manageability and security, while lowering total cost of ownership.

- ASUS
The ESC8000 G3 is the first VCA certified GPU server from Nvidia. Users can enjoy improved efficiency, scalability and performance in a single platform that decreases their time to market and costs.

- Advantech
Advantech WebAccess/Cloud is a cloud-based software platform that supports MQTT protocol and provides plug-and-play capability that enables big data analysis for Industry 4.0 services.

- VIVOTEK
The H.265 VAIR Long Range Speed Dome Camera is the latest professional speed dome camera from VIVOTEK that is specifically designed to enhance low light surveillance over areas that require large coverage.

- Planet
Based on its green technology, Planet's Renewable Energy Industrial 802.3at PoE Managed Ethernet Switch can be charged via the inexhaustible and natural sources of solar, wind and hydroelectric power. It can especially be used for expansive locations, such as dams, forests, deserts, national parks, nature and animal protected areas, and highways.

- Industrial Technology Research Institute of Taiwan (ITRI)
NSOS (next-generation system software for smartphone) is designed to increase the added value of commodity Android phones by solving the BYOD (bring your own device) security problem via virtualization, providing more personalized services via accurate inference of dynamic user interest, and offering more streamlined user experiences via programmatic app control.

About the Taiwan Excellence Award

The symbol of Taiwan Excellence honors Taiwan's most innovative products that provide tremendous value to users worldwide. All products carrying this symbol have been selected for specific Taiwan Excellence Awards based on their excellence in design, quality, marketing, Taiwanese R&D, and manufacturing. Initiated by Taiwan's Ministry of Economic Affairs (MOEA) in 1992, the symbol of Taiwan Excellence is recognized in 100 countries.

Supported by Bureau of Foreign Trade (BOFT), MOEA

The Bureau of Foreign Trade (BOFT) under the Ministry of Economic Affairs (MOEA), R.O.C. is responsible for implementing policies and regulations governing foreign trade and economic cooperation. Established in January 1969, the BOFT's role and position have been adjusted regularly to meet the needs of the ever changing international economic and trade environments. The BOFT has been guiding and working with the Taiwan External Trade Development Council (TAITRA) in numerous promotional trade projects and activities both internationally and domestically. Having worked closely with TAITRA for many decades, the BOFT continues to commission TAITRA for various critical government projects relating to business, trade and investment, while promoting Taiwan internationally.

Organized by Taiwan External Trade Development Council (TAITRA)

Founded in 1970 to help promote foreign trade, the Taiwan External Trade Development Council (TAITRA) is the foremost non-profit, semi-governmental trade promotion organization in Taiwan. Jointly sponsored by the government, industry associations, and several commercial organizations, TAITRA assists Taiwanese businesses and manufacturers with reinforcing their international competitiveness and in coping with the challenges they face in foreign markets. TAITRA boasts a well-coordinated trade promotion and information network of over 1,200 international marketing specialists stationed throughout its Taipei headquarters and 50 offices worldwide. Together with its sister organizations, the Taiwan Trade Center (TTC) and the Taipei World Trade Center (TWTC), TAITRA has created a wealth of trade opportunities through effective promotion strategies.

For Media Enquiries

TAITRA
Ya Hsing Lu
Strategic Marketing Department, TAITRA
HP: +886 2 2725 5200 #1386
Email: yahsing@taitra.org.tw

PRecious Communications for TAITRA
Melinda Ilagan
Tel: +65 6303 0567
Email: taitra@preciouscomms.com

Moscow, Russia and Tokyo, Japan, May 19, 2017 - (ACN Newswire) - JCB International Co., Ltd. (JCBI), the international operations subsidiary of JCB Co., Ltd., announced the signing of a license agreement with Sberbank of Russia, the largest bank in Russia, the Commonwealth of Independent States (CIS) and Central and Eastern Europe. Sberbank agreed to start accepting JCB cards on the Sberbank nationwide POS terminal network in 2018.

Sberbank has the largest POS terminal network in the country. JCBI started card issuing business with several local banks in Russia in 2015 and the cardmember base has been expanding. The partnership with Sberbank of Russia will ensure that the JCB cardmembers enjoy more convenience and increase JCB brand awareness and presence in the market.

Kimihisa Imada, President and COO of JCBI, said: "We are sure this arrangement will support our objective as a very active player in the payment industry in Russia. We believe our collaboration will contribute to the growth of card payments and provide greater convenience to JCB cardmembers both in Russia and from all over the world."

About JCB

JCB is a major global payment brand and a leading payment card issuer and acquirer in Japan. JCB launched its card business in Japan in 1961 and began expanding worldwide in 1981. Its acceptance network includes about 32 million merchants and over a million cash advance locations in 190 countries and territories. JCB cards are now issued in 23 countries and territories, with more than 100 million card members. As part of its international growth strategy, JCB has formed alliances with hundreds of leading banks and financial institutions globally to increase merchant coverage and card member base. As a comprehensive payment solution provider, JCB commits to provide responsive and high-quality service and products to all customers worldwide.

Note: Statistics in About JCB are as of September 2016.

For more information, please visit: www.global.jcb/en/ or www.ru.jcb/ru/ .

Contact
JCB International Co., Ltd.
Kae Mitsuda
Global Business Planning
Tel: 81-3-5778-7963
Email: jcbinternational-pr@info.jcb.co.jp

New Company to Be Considered for Supporting Strategic Construction and for Achieving Wider Use of FCVs and Independence of Hydrogen Station Business

Toyota City, Japan, May 19, 2017 - (JCN Newswire) - Toyota Motor Corporation, Nissan Motor Co., Ltd., Honda Motor Co., Ltd., JXTG Nippon Oil & Energy, Idemitsu Kosan Co., Ltd., Iwatani Corporation, Tokyo Gas Co., Ltd., Toho Gas Co., Ltd., Air Liquide Japan Ltd., Toyota Tsusho Corporation and Development Bank of Japan Inc. have signed a memorandum of understanding on collaboration toward the large-scale construction of hydrogen stations for fuel cell vehicles (FCVs).

The memorandum of understanding is aimed at achieving the acceleration of the construction of hydrogen stations in the current early stage of FCV commercialization using an "all Japan" approach centered on collaboration among the 11 companies. It stems from the Japanese government's "Strategic Roadmap for Hydrogen and Fuel Cells"(1) (revised on March 22, 2016), which targets a total of 160 operational hydrogen stations and 40,000 in-use FCVs by fiscal 2020.

Recognizing the challenges facing the hydrogen station business in early-stage commercialization of FCVs, the memorandum of understanding is based on the idea that the companies concerned should cooperate and fulfill their respective roles(2) to achieve the strategic development of hydrogen stations for maximizing FCV demand and to contribute to the steady popularization of FCVs.

As a specific form of such cooperation, the 11 companies will consider establishing a new company within 2017. The new company would aim to: 1) achieve steady construction of hydrogen stations by implementing measures to support hydrogen-station construction and operation, and 2) achieve wider use of FCVs and the independence of the hydrogen station business through activities for reducing costs, including governmental review of regulations, and activities for improving operational efficiencies, thus contributing to the realization of a hydrogen society in Japan.

The 11 companies will consider ways for broad participation by other companies in the future and will disseminate information appropriately.

(1) Compiled by Japan's Ministry of Economy, Trade and Industry and announced on June 23, 2014
(2) Role of each company
Infrastructure Companies: Construction and operation of hydrogen stations FCV OEMs: Spread of FCVs, operational support for hydrogen stations Financial institutions: Financial support, etc.

About Toyota

Supported by people around the world, Toyota Motor Corporation (TSE: 7203; NYSE: TM), has endeavored since its establishment in 1937 to serve society by creating better products. As of the end of December 2013, Toyota conducts its business worldwide with 52 overseas manufacturing companies in 27 countries and regions. Toyota's vehicles are sold in more than 170 countries and regions. For more information, please visit www.toyota-global.com.

Contact:
Public Affairs Division
Global Communications Department
Toyota Motor Corporation
Tel: +81-3-3817-9926

TOKYO, May 19, 2017 - (JCN Newswire) - Mitsubishi Motors Corporation (MMC) announced today that cumulative engine production reached five million units at Shenyang Aerospace Mitsubishi Motors Engine Manufacturing Co., Ltd. (SAME), MMC's engine joint-venture in Shenyang, China.

SAME was established in August 1997 and started production in 1998. Supplying engines to Mitsubishi Motors brand as well as several Chinese automakers in the expanding auto market in China, cumulative production at the company reached three million units in 2014 and four million units in 2016.

MMC President, CEO Osamu Masuko attended the commemoration ceremony and stated: "Mitsubishi Motors is very proud of achieving this milestone, having produced five million engines, at China's leading engine supplier, Shenyang Aerospace Mitsubishi Motors Engine Manufacturing Co., Ltd. (SAME). This represents a 25% increase from last year and demonstrates the strong growth in the passenger car segment. That gives us great confidence in the future of SAME, and Mitsubishi Motors is excited to be able to contribute to the continued development of the Chinese automotive industry."

SAME started production of the 4A9 engine in June 2009. Used to power small cars, this low displacement and lightweight unit incorporates MMC's eco-friendly MIVEC (Mitsubishi Innovative Valve Timing Electronic Control) variable valve timing mechanism. SAME sold 750,000 units of engines in 2016. SAME also have launched the production of 4K2 series as the successor to the 4G6 engine, expanding its business to support the market demands with high-quality products in timely manner.

SAME is currently focusing on strengthening its product lineup and improving environmental performance in order to meet the diversifying needs of the Chinese market as it continues to contribute to the growth and development of the Chinese auto industry.

Outline of Shenyang Aerospace Mitsubishi Motors Engine Manufacturing Co., Ltd.

Headquarters: Shenyang, Liaoning province
Established: August 1997 (started production in August 1998)
Major shareholders:
China Aerospace Automotive Industry Group Co. - 30%
Mitsubishi Motors Corporation - 25%
Shenyang Jianhua Motors Engine Co., Ltd. - 21%
MCIC Holdings Sdn. Bhd. - 14.7%
Mitsubishi Corporation - 9.3%
Production lines: 4G6 engine (2.0L, 2.4L), 4A9 engine (1.3L, 1.5L, 1.6L), 4K2 engine (1.8L, 2.0L, 2.4L)
Production volume: 748,353 units (CY2016)

About Mitsubishi Motors

Mitsubishi Motors Corporation is the fifth largest automaker in Japan and the fifteenth largest in the world by global unit sales. It is part of the Mitsubishi keiretsu, formerly the biggest industrial group in Japan, and was formed in 1970 from the automotive division of Mitsubishi Heavy Industries.

Throughout its history it has courted alliances with foreign partners, a strategy pioneered by their first president Tomio Kubo to encourage expansion, and continued by his successors. A significant stake was sold to Chrysler Corporation in 1971 which it held for 22 years, while DaimlerChrysler was a controlling shareholder between 2000 and 2005. Long term joint manufacturing and technology licencing deals with the Hyundai Motor Company in South Korea and Proton in Malaysia were also forged, while in Europe the company co-owned the largest automobile manufacturing plant in the Netherlands with Volvo for ten years in the 1990s, before taking sole ownership in 2001.

Contact:
Mitsubishi Motors
Public Relations Department
http://www.mitsubishi-motors.com 
+81-3-6852-4275

HKTDC Entrepreneur Day Opens with Record Exhibitors

Star speakers discuss tech trends and opportunities

HONG KONG, May 19, 2017 - (ACN Newswire) - The ninth edition of the HKTDC Entrepreneur Day opened today to a record of more than 270 exhibitors. Organised by the Hong Kong Trade Development Council (HKTDC), the two-day event (19 to 20 May) is taking place at the Hong Kong Convention and Exhibition Centre and is open to the public for free.

"The event is the HKTDC's flagship event for entrepreneurs," said HKTDC Executive Director Margaret Fong. "As more and more young people become interested in entrepreneurship, their demand for start-up support is continually rising."

- Start-up Runway

Lau Ming-Wai, Chairman of the Commission on Youth, officiated at this morning's opening session of Start-up Runway. Entrepreneur Day's two-day flagship conference kicked off with a plenary session titled "Vision Explorer: Venturing into the Future". Among the speakers who shared their entrepreneurship experience were Simon Loong, co-founder and CEO of WeLab Holdings, one of the world's top FinTech companies (ranked 33rd globally and sixth in China); Terence Kwok, co-founder of Tink Labs Ltd, which raised US$100 million in a recent funding round; and Shing Chow, founder and CEO of Lalamove. The forum was moderated by StartupsHK's co-founder Gene Soo.

More than 40 seminars, workshops and networking activities will be held during Entrepreneur Day, featuring entrepreneurs and start-ups from different sectors who will discuss innovation and technology trends and start-up opportunities, offer professional advice to fledgling entrepreneurs and share experiences and insights. Speakers will include Carman Chan, Managing Partner of Click Ventures, which provides mentorship to companies specialising in Internet, mobile and related technologies (its portfolio includes Spotify and Meetup); Samson Tam, Partner of Hong Kong Innovation Angel Investment Ltd, an active angel investor that has invested in more than a dozen start-ups; Jason Chiu, CEO of cherrypicks, whose entrepreneurial journey was featured as a Harvard Business School case study; James Hong, renowned travel writer; Antonia Li, Research Analyst of Oddup; and Alex Kong, founder and CEO of TNG Wallet, Hong Kong's home grown eWallet. A diverse range of hot topics will be examined at the events, including Fintech, AI and TravelTech.

- Experience innovative technology in action

Creativity, sound planning and market intelligence are key components to every entrepreneurial success. This year's Entrepreneur Day features a new exhibition zone called The Imaginarium, which gathers more than 60 start-ups to showcase the latest innovative products and technologies in the fields of health technology and biotechnology, FinTech, greentech, IoT (Internet of Things), artificial and augmented reality (AR/VR), artificial intelligence (AI) and robotics. A number of local tertiary institutions and tech companies are also on site to showcase their work. Visitors can experience the latest innovative technology and creative concepts from different sectors and technical domains at the zone. Visitors can see various tech innovations and systems in action at the Imaginarium Demo Area, which will showcase start-up cases and live demonstrations by tech and tertiary institutions and co-working spaces, including the Hong Kong Cyberport Management Company Ltd, The Chinese University of Hong Kong and playground.work.

Other highlight zones include: Go-getters Zone, which showcases business opportunities for start-ups; The Boosters, where support services are offered; The Cosmopolitan, which features start-up cases from overseas and the Chinese mainland; and Creatopia - Cross Matching Pavilion, a platform that promotes local creative designers and cross-sector business cooperation.

- Pitching for funding

For start-ups to thrive, capital is crucial, and pitching is one of the main ways for start-ups to seek funding. This year's Pitchathon is co-organised by StartHub, the Hong Kong Startup Council and Cocoon. The event aims to provide start-ups and investors with an exchange platform where start-ups can hone their pitching skills and seek funding and compete for a chance to secure angel investment. At this year's StartHub 3.0 Pitching Competition, winning projects have the chance to receive up to HK$20 million in funding.

- Sparking entrepreneurial ideas, building connections

Building connections is another indispensable component of entrepreneurship. Entrepreneurs need the support of like-minded peers and expert advice. At Entrepreneur Day, the HKTDC together with the Hong Kong Federation of Youth Groups has organised the Start-up Mixer, a two-hour event that uses the "speed dating" format to allow more than 70 start-ups to interact with 12 star mentors from different sectors and receive business advice.

In addition, the HKTDC is co-organising the Startup Weekend Hong Kong Bootcamp with Startup Weekend Hong Kong. The event allows fledgling entrepreneurs to compete with each other and experience the entrepreneurial journey, brainstorm ideas and turn them into viable businesses. Another new event, The Pioneer Meetup, offers a platform for start-ups to exchange ideas with young leaders and successful entrepreneurs. The HKTDC is also launching an event with W-Hub, called Start-ups Meet Talent, which allows start-ups to meet prospective teammates, conduct interviews and hire staff. Meanwhile, the acclaimed Fund & Mentor business-matching event returns, offering an opportunity for start-ups to explore cooperation with potential investors.

Entrepreneur Day website: www.hktdc.com/eday
Photo download: http://bit.ly/2qA7AWT

To view press releases in Chinese, please visit http://mediaroom.hktdc.com/tc

About HKTDC

Established in 1966, the Hong Kong Trade Development Council (HKTDC) is a statutory body dedicated to creating opportunities for Hong Kong's businesses. With more than 40 offices globally, including 13 on the Chinese mainland, the HKTDC promotes Hong Kong as a platform for doing business with China, Asia and the world. With 50 years of experience, the HKTDC organises international exhibitions, conferences and business missions to provide companies, particularly SMEs, with business opportunities on the mainland and in international markets, while providing information via trade publications, research reports and digital channels including the media room. For more information, please visit: www.hktdc.com/aboutus. Follow us on Google+, Twitter @hktdc, LinkedIn.

Google+: https://plus.google.com/+hktdc
Twitter: http://www.twitter.com/hktdc
LinkedIn: http://www.linkedin.com/company/hong-kong-trade-development-council

Contact:
HKTDC
Communication and Public Affairs Department
Joe Kainz
Tel: +852 2584 4216
Email: joe.kainz@hktdc.org

Record More Than 17,600 Visitors Attend HKTDC Entrepreneur Day

Start-up Runway in Hong Kong Explores Entrepreneurial Vision

HONG KONG, May 21, 2017 - (ACN Newswire) - A record turnout of more than 17,600 visitors, 3.5 per cent more than the previous year, attended Entrepreneur Day on 19-20 May at the Hong Kong Convention and Exhibition Centre (HKCEC). Organised by the Hong Kong Trade Development Council (HKTDC), the two-day event hosted more than 270 exhibitors from various sectors for its ninth edition.

"Vision Explorer: Venturing into the Future" was the theme of the Start-up Runway forum which took place on both days of the event, featuring successful entrepreneurs from a wide range of industries who shared start-up experiences and insight. Opening day plenary session speakers included Ming-wai Lau, Chairman of the Commission on Youth and Gene Soo, Co-founder of StartupsHK, joining local start-up entrepreneurs Simon Loong of FinTech giant WeLab Holdings, Shing Chow of logistics platform Lalamove and TravelTech pioneer Terence Kwok of Tink Labs Limited.

- Age Doesn't Matter

"Starting up a business is not just the dream of the youth," said Mr Lau. "According to some overseas surveys, the average age of entrepreneurs is about 40. It's never too late if one wants to start their own business."

Mr Loong recalled quitting his job at the age of 36 to become an entrepreneur after he came up with the idea of building his online loan platform WeLab Holdings. "I used to work in the loan department of a bank and found that personal loans could solve one's financial difficulties. However, loan applicants had to go to the bank in person to sign documents and their application might eventually be declined. So, the idea of combining the strengths of traditional banks in risk management and treasury management with innovative big data technologies popped into my head," he recalled. "Capitalising on big data and loan applications that can be approved round-the-clock without face-to-face contact, a deeper understanding of people can be achieved."

A straight-A student and Stanford University graduate, Shing Chow of Lalamove wanted to change the world as an entrepreneur. "The process of hiring a van is no longer a manual task since digital took over, and I saw this change as the opportunity of a lifetime. There is an old saying about how if you don't study hard as a child, you will end up as a transport worker - but studying hard led me to this sector. In the past, people thought this city was only strong at property development and finance, but as Hong Kong becomes more tech-driven, we can change the way people think."

- Taking on the World

Fast-growing start-ups should view the global market as part of their recipe for success, according to Mr Lau of the Commission on Youth. He encouraged entrepreneurs to develop not only in Hong Kong, but on the Chinese mainland and in overseas markets as their personal goals, business nature or products and services lead them. "Global connectivity is a double-edged sword," he said. "This means that global interaction becomes more frequent as competition increases, and entrepreneurs with a focus on the worldwide market can take things to a higher level."

Targeting youth aged 25 to 30, WeLab has built up a base of more than 17 million users, according to Mr Loong, who has learned that some start-ups can enjoy exponential growth when they are not dependent on face-to-face contact. A report called "Fintech 100 - Presenting the world's leading Fintech innovators for 2016" by KPMG, ranked WeLab sixth on the mainland and 33rd in the world. "Every country or region has its own regulations. So, we chose to open the huge market in our vicinity, the Chinese mainland," said Mr Loong.

Mr Chow of Lalamove said his entrepreneurial team has a strong commitment to success and his team members are willing to live in different cities to expand their business. While Mr Kwok of Tink Labs recalled studying philosophy and Arabic at the University of Chicago before dropping out to try and cater to the needs of travellers. He started with a service offering mobile phone handset rental at airports before widening the offer to include rental handsets and tablets at hotels around the world. He said a focus on "how to kickstart a business" was "not important, since the business model keeps on evolving."

- No Pain, No Funds

Speaking about persistent cash-flow problems entrepreneurs face, Ming-wai Lau noted that a range of sources should be pursued, with Hong Kong SAR Government assistance schemes and events such as Entrepreneur Day offering potential avenues for fundraising.

"The performance of the financing market is more volatile than that of the real economy. In 2014, O2O went hot, and investors responded swiftly with an actual investment amount. However, the trend reversed in late 2015," said Shing Chow of Lalamove. "We met with over 50 prospective investors, but none showed any interest. Venture capitalists have been hunting for unicorn start-ups (with an estimated valuation of US$1billion or above), and this is one major reason why we were being rejected."

But even Hong Kong's prospected "unicorn" start-up, Tink Labs, has hit fundraising roadblocks. "We were turned down more than 50 times. Don't take it too seriously when being rejected. Sticking to your beliefs and persistence counts," Mr Kwok said.

A popular method of fundraising is pitching, and Entrepreneur Day offered a forum for entrepreneurs in the form of pitching events, organised with StartHub, Hong Kong Startup Council and Cocoon, connecting start-ups with potential angel investors.

Entrepreneur Day website: www.hktdc.com/eday
Photo download: http://bit.ly/2q5MDPS

To view press releases in Chinese, please visit http://mediaroom.hktdc.com/tc

(Photo:) Noting that an entrepreneur's character is a key to success, Ming-wai Lau, Chairman of the Commission on Youth, said most entrepreneurs are curiosity-driven, willing to seek solutions and learn from the others.

About HKTDC

Established in 1966, the Hong Kong Trade Development Council (HKTDC) is a statutory body dedicated to creating opportunities for Hong Kong's businesses. With more than 40 offices globally, including 13 on the Chinese mainland, the HKTDC promotes Hong Kong as a platform for doing business with China, Asia and the world. With 50 years of experience, the HKTDC organises international exhibitions, conferences and business missions to provide companies, particularly SMEs, with business opportunities on the mainland and in international markets, while providing information via trade publications, research reports and digital channels including the media room. For more information, please visit: www.hktdc.com/aboutus. Follow us on Google+, Twitter @hktdc, LinkedIn.

Google+: https://plus.google.com/+hktdc
Twitter: http://www.twitter.com/hktdc
LinkedIn: http://www.linkedin.com/company/hong-kong-trade-development-council

Contact:
HKTDC
Communication and Public Affairs Department:
Joe Kainz
Tel: +852 2584 4216
Email: joe.kainz@hktdc.org

Image of the completed new plant (left) at DENSO Fukuhsima

KARIYA, JAPAN, May 22, 2017 - (JCN Newswire) - DENSO Corporation today announced that it will build an additional plant at its DENSO Fukushima location in Tamura city, Fukushima Prefecture, Japan, to diversity its manufacturing lineup to include powertrain components, which will enhance the competitiveness of the group's production system Japan. The company will invest about US$135 million (approx. 15 billion yen) by 2023 to build the new plant and expand production. The project will start in August 2017 and will be completed in July 2018. Production will begin in October 2018 in stages. The number of employees required will increase to around 600 by 2023.

DENSO Fukushima currently manufactures automotive thermal systems, including air conditioning systems and engine cooling modules (ECMs). The new plant will manufacture fuel pumps and injectors for gasoline engine fuel systems. Furthermore, this expansion aims to serve as a DENSO Group production base in eastern Japan, and will improve its capability to meet customer needs and contribute to the development of the local community.

About Denso

DENSO Corporation, headquartered in Kariya, Aichi prefecture, Japan, is a leading global automotive supplier of advanced technology, systems and components in the areas of thermal, powertrain control, electronics and information and safety. Its customers include all the world's major carmakers. Worldwide, the company has more than 200 subsidiaries and affiliates in 38 countries and regions and employs nearly 140,000 people. Consolidated global sales for the fiscal year ending March 31, 2014, totaled US$39.8 billion. Last fiscal year, DENSO spent 9 percent of its global consolidated sales on research and development. DENSO common stock is traded on the Tokyo and Nagoya stock exchanges. For more information, go to www.globaldenso.com, or visit our media website at www.densomediacenter.com.

Contact:
Sadayoshi Yokoyama, Toshiko Watanabe 
DENSO CORPORATION 
Phone: 81-566-25-5594 
Fax: 81-566-25-4509 
sadayoshi_yokoyama@denso.co.jp 
toshiko_watanabe@denso.co.jp

- Nobel Prize nominee Daryl Thompson to lead research, conducted by Global BioLife Inc., supported by Charles River Laboratories
- Six month target for validating lab data, twelve month target for completion of platform

SINGAPORE, May 22, 2017 - (ACN Newswire) - Singapore eDevelopment Ltd ("SeD"), through subsidiary Global BioLife Inc. ("Global BioLife"), has initiated advanced research on a new universal therapeutic drug platform known as Linebacker, to combat a range of diseases including Alzheimer's, diabetes and cancer. The research will be led by two-time Nobel Prize nominee Mr Daryl Thompson.

SGX-listed SeD (SP:SGE) said Mr Thompson would leverage his expertise in organic and carbohydrate chemistry and the use of pandemic technology in combating the Ebola virus in the development of Linebacker. Unlike traditional approaches to curing individual diseases with specific drugs, the Linebacker platform seeks a breakthrough option for multiple diseases to be cured. It can also potentially combat drug-resistant viruses and antibiotic-resistant bacteria.

Mr Thompson will lead the research, to be conducted by Global BioLife, in his capacity as Director of Scientific Initiatives. Global BioLife is an 80%-held subsidiary of SeD's wholly-owned subsidiary, Global BioMedical Inc. The remaining stake in Global BioLife is held in equal proportions by Mr Thompson's GRDG Sciences LLC and ASX-listed Holista CollTech Limited.

Mr Thompson was nominated for a Nobel Prize in 2015 and 2016 for his research in cutting-edge organic and carbohydrate chemistry as well his research in pandemics technology to fight pandemics such as Ebola. He has used his expertise to initiate research regarding universal therapeutics to cure the world's deadliest diseases. Mr Scott Truesdell, Research Coordinator and Special Projects Leader at Global BioLife, will execute the research on the Linebacker platform.

Global BioLife has engaged NYSE-listed Charles River Laboratories International, Inc., which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts.

Mr Thompson said, "We expect to obtain validating laboratory data from the universal therapeutic drug platform within the first six months and are targeting for the platform itself to be completed within twelve months. We have a unique patented technology and are already getting interest from Big Pharma players and venture capitalists. This interest will rise as the validating data becomes available."

"Global BioLife recognizes the need for affordable cures to emerging pandemics and we will leverage the team's deep expertise to develop this new universal therapeutic drug platform," said Dr Tang Peihong, Global BioLife Director and CEO. Dr Tang has a Ph.D. in Chemical Engineering and was selected as National Distinguished Expert in China's Thousand Talents Plan in 2012.

GRDG Sciences LLC is a natural products discovery drug research company formed in Florida, USA by Mr Thompson, a natural products scientist. GRDG Sciences works with multiple global institutions such as Charles River. Holista CollTech Ltd is a research-driven biotech company that resulted from the merger of Holista Biotech Sdn Bhd and CollTech Australia Ltd. It is dedicated to delivering first-class natural ingredients and wellness products (www.holista.com).

About Singapore eDevelopment Limited

Incorporated on 9 September 2009, and listed on the Singapore Exchange Catalist (SGX:40V) in July 2010 (SP: SGE; SINE), Singapore eDevelopment is involved in (i) property development and investments primarily in the United States and Western Australia; (ii) Information Technology-related businesses; (iii) development, research, testing, manufacturing, licensing and distribution of biomedical products; and (iv) investment activities. For more information, please visit: www.SeD.com.sg.

Issued on behalf of the Company:
WeR1 Consultants Pte Ltd
Mr Ian Lau
E: ianlau@wer1.net
T: +65 6737 4844
Singapore 048693

Car 12 (Esapekka Lappi, Janne Ferm)

Car 10 (Jari-Matti Latvala, Miikka Anttila)

Toyota City, Japan, May 22, 2017 - (JCN Newswire) - TOYOTA GAZOO Racing World Rally Team has finished one of the most demanding rallies of the year with all three cars in the top 10, after entering a trio of drivers for the first time. Making his debut was Esapekka Lappi, who claimed two points by setting fourth-fastest time on the Power Stage. Juho Hanninen was seventh, Jari-Matti Latvala was ninth despite not feeling well, and Lappi was 10th.

http://www.acnnewswire.com/topimg/Low_ToyotaWRCCar12.jpg
Car 12 (Esapekka Lappi, Janne Ferm)

The final day of Rally Portugal consisted of four stages run consecutively without service, including two passes on the famous Fafe stage. After encountering varied issues over the previous two days, the Toyota drivers concentrated on bringing all three cars safely home to consolidate the team's third spot in the manufacturers' standings. An unexpected bonus was Lappi's driver points on the Power Stage.

http://www.acnnewswire.com/topimg/Low_ToyotaWRCCar10.jpg
Car 10 (Jari-Matti Latvala, Miikka Anttila)

Quotes:

Tommi Makinen (Team Principal)
"This was another very difficult rally from which we will learn a lot from the future. I'm particularly happy about the way it finished, with Esapekka doing a fantastic job to score three driver points on his debut. The way that he quickly came up to speed was very impressive and I am sure he has a strong future. But I would like to thank all of our drivers, co-drivers and team. Juho did a very solid job to score more driver points and without a couple of small issues he could have been even higher. He proved again how important he is to our programme. We were actually very worried about Jari-Matti's physical condition yesterday, but he overcame that to finish the rally strongly. The team has put into place everything we have learned so far very effectively. Now we will continue working in this way."

Jari-Matti Latvala (Driver car 10)
"Physically, this is the hardest rally I have ever done in my career. I was feeling terrible yesterday, but I spent the night in hospital to rehydrate and as a result I felt a lot better today and we were able to finish in the points, which I am very happy about. There's no test before Sardinia, so I have a chance to rest properly--I think I could sleep now for the next two days!--and come back even stronger for the next rally."

Juho Hanninen (Driver car 11)
"I'm happy to end another rally in a points-scoring place, especially because we didn't have much experience here and conditions were quite tricky, although not quite as bad as Argentina. The most important thing is that we learned a lot and generally had a clean run: this helps the confidence. Today we were trying a couple of different things for the future, and I had a lot of fun on the Fafe stage: the crowds were amazing and it was a fantastic experience, so thank you to them as well."

Esapekka Lappi (Driver car 12)
"To be honest, before the rally I was hoping that we could score points in the overall classification, but I would never have dreamed of it happening on the Power Stage. So in many ways, this rally didn't exactly go as I expected, but I'm happy: I think we found the right speed, which is very important. On the first two stages today I tried to save the tyres, then on the two final ones I could push harder. My landing after the jump on the Fafe Power Stage was interesting--but at least I could demonstrate how tough the suspension on the Yaris WRC is!"

For the latest results please visit www.wrc.com.

What's next?:

The next round of the World Rally Championship is Rally Italia Sardegna from June 8-11, after a three-week break. This is another event that takes place on soft and sandy gravel, which takes a lot out of the cars and drivers. Temperatures are likely to be high, which increases the challenge, and there will once more be three Yaris WRCs taking the start, for Latvala, Hanninen and Lappi.

About Toyota

Supported by people around the world, Toyota Motor Corporation (TSE: 7203; NYSE: TM), has endeavored since its establishment in 1937 to serve society by creating better products. As of the end of December 2013, Toyota conducts its business worldwide with 52 overseas manufacturing companies in 27 countries and regions. Toyota's vehicles are sold in more than 170 countries and regions. For more information, please visit www.toyota-global.com.

Contact:
Public Affairs Division
Global Communications Department
Toyota Motor Corporation
Tel: +81-3-3817-9926

Mr. Yang posed for pictures with Mr. Russell Flannery, bureau chief of Forbes magazine.

Among three outstanding awardees in food industry

HONG KONG, May 22, 2017 - (ACN Newswire) - Tianyun International Holdings Limited ("Tianyun International", together with its subsidiaries, the "Group") (6836.HK), a leading seller and manufacturer of processed fruits products in China, is pleased to announce that the Group was awarded "2017 China's Most Promising Listed Companies" by Forbes China, and is the only fast-growing enterprise in the Chinese processed fruits market receiving the honor.

2017 Forbes China Most Promising Listed Companies awards are given to the shortlisted 100 most promising listed companies in China, US and Hong Kong, with turnover in 2015 amounting RMB10 million to RMB1 billion and core business located in China. Most of the awardees come from medical and technological industry, while only 3 companies are in food industry, including Tianyun International. It has been 12 years since "Forbes China", a branded international business publication, started the comprehensive yet independent research on Chinese growing enterprises. The award is regarded as one of the most authoritative recognitions to the companies.

Upholding our stringent safety and quality requirement, the Group is endeavor to developing diversified processed fruit products to consumers. In 2016, Shandong Tiantong Food Co., Ltd, a subsidiary of the Group, received a "Same production line, Same standard, Same quality" recognition jointly issued by Shandong Linyi Entry-Exit Inspection and Quarantine Bureau and Linyi Municipal Bureau of Commerce, proving that our local products reach the same quality level as the products being exported.

Moreover, mixed fruit puree product launched by the Group was included in the "displayed products in future supermarkets" in the American PLAM own brand exhibition, indicating the global recognition received in terms of the Group's research and development, as well as the remarkable capability to seize the future trend in food industry. The total turnover of the Group recorded a 18.1% Y-o-Y growth to RMB653 million. The turnover from own brand business even recorded a significant Y-o-Y growth of 87.3%.

Mr. Yang Ziyuan, Chairman and CEO of the Group commented "We are honored to receive the recognition from Forbes, a globally well-known business publication, after we became the only fruit processor in the industry to receive the qualification of "China Canned Product Quality Certification Label" from China Canned Food Industry Association with products identified as the "Zero Added Preservative Canned Products" in 2016.

Looking ahead, we will continue to steadily develop both own brand and OEM business to seize the opportunities brought by the fast-growing own brand business and increasing brand awareness, by keep developing new products for a better sales performance. 4-5 new products are expected to be launched within the year. Meanwhile, we will insist on providing natural, safe and high quality products to customers, as well as driving our business growth and further consolidating the Group's market leadership."

About Tianyun International Holding Limited (HKSE: 6863)

Tianyun International Holdings Limited and its subsidiaries (the "Group") are principally engaged in (i) the production and sales of branded processed fruit products and (ii) trading of fresh fruit. Processed fruit products are sold both on an OEM basis and under its own brands - "Tiantong Times", "Bingo Times" . On 7 July 2015, the Group was successfully listed on the Main Board of the Stock Exchange, which would further consolidate our leading position in China's processed fruit industry.

With its commitment to provide customers with healthy and safe products, the Group has always been dedicated to stringent production standards and is accredited with BRC(A+), IFS Food (High), HALAL, SC, KOSHER, ISO22000, "China Canned Product Quality Certification Label" and "Zero added preservative canned products" top-tier international and local certifications. For more information, please visit www.tianyuninternational.com.

NEC to Conduct Remote Construction Trial Utilizing 5G with KDDI and Obayashi

Mitsubishi Hitachi Power Systems Opens New Warsaw Office Improving customer support in Poland

Nanobiotix Announces First Positive Human Data Showing That NBTXR3 Could Become a Backbone in Immuno-Oncology

Wintermar Offshore (WINS.JK) Shareholders approve Placement of Shares and new Board Directors

HKBU Chinese Medicine Scholars Conduct Research in Space Life Science aboard China's Tianzhou 1

Hong Kong International Medical Devices and Supplies Fair Concludes

Chiho-Tiande Announces Business Updates

Microbiome leader Professor Borody calls for a National Australian FMT Bank to fight Drug Resistant Diseases

ASL Celebrates Its 20th Listing Anniversary and Successful Acquisition of Grid Dynamics

Mitsubishi Motors Starts Major Renovation for R&D Center in Okazaki

Taiwan Excellence Pavilion Gathers Formidable Tech Innovators on Its Debut at CommunicAsia 2017

Sberbank of Russia to Start Accepting JCB Cards

11 Companies Agree to Collaborate on Large-scale Construction of Hydrogen Stations

Mitsubishi Motors: China Joint-venture Reaches 5,000,000 Engines Produced

HKTDC Entrepreneur Day Opens with Record Exhibitors

Record More Than 17,600 Visitors Attend Entrepreneur Day

DENSO to Expand its Fukushima, Japan location as Part of Efforts to Enhance the DENSO Group Production System

Singapore eDevelopment Subsidiary Initiates Research on New Universal Therapeutic Drug Platform

All Three Yaris WRCs in Top 10: Power Stage Points for Lappi on Debut

Tianyun International Awarded 2017 China's Most Promising Listed Companies by Forbes China